The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
ARID1A Mutations in Cancer: Another Epigenetic Tumor Suppressor?
Open accessAbstract
Although disordered chromatin organization has long been recognized as a feature of cancer, the molecular underpinnings of chromatin structure, epigenetic regulation, and their relationships to transcription are only beginning to be understood. Cancer genome sequencing studies have revealed a novel theme: frequent mutation of epigenetic regulators. Among these, the ARID1A/BAF250A subunit of the SWI/SNF (BRG1-associated factors) chromatin remodeling complex has emerged as recurrently mutated in a broad array of tumor types. We review the genomic and functional data supporting classification of ARID1A as a tumor suppressor. Significance: Mutations in chromatin remodeling complex genes are increasingly recognized in many cancer types. However, the mechanisms by which chromatin remodeling complexes contribute to gene expression and the cancer phenotype are poorly understood. Understanding how mutation of chromatin remodelers facilitates transformation may offer the potential for development and implementation of novel therapies for cancer. Cancer Discov; 3(1); 35–43. ©2012 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
Guichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
Large-scale characterization of HeLa cell nuclear phosphoproteins
Beausoleil, S. A., Jedrychowski, M., Schwartz, D., Elias, J. E., Villén, J., Li, J., Cohn, M. A., Cantley, L. C., & Gygi, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404720101 · Cited by 1,375
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
SWI/SNF nucleosome remodellers and cancer
Wilson, B. G., & Roberts, C. W. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3068 · Cited by 1,282
Self-citationFrequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C. K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,123
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
Hargreaves, D. C., & Crabtree, G. R. (2011) · Cell Research · doi:10.1038/cr.2011.32 · Cited by 923
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Novel mutations target distinct subgroups of medulloblastoma
Robinson, G., Parker, M., Kranenburg, T. A., Lu, C., Chen, X., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 846
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Reconstitution of a Core Chromatin Remodeling Complex from SWI/SNF Subunits
Phelan, M. L., Sif, S., Narlikar, G. J., & Kingston, R. E. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80315-9 · Cited by 627
The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest
Dunaief, J. L., Strober, B. E., Guha, S., Khavari, P. A., Ålin, K., Luban, J., Begemann, M., Crabtree, G. R., & Goff, S. P. (1994) · Cell · doi:10.1016/0092-8674(94)90405-7 · Cited by 624
Zang, Z. J., Cutcutache, I., Poon, S. L., Zhang, S. L., McPherson, J. R., Tao, J., Rajasegaran, V., Heng, H. L., Deng, N., Gan, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2246 · Cited by 616
Self-citationThe SWI/SNF complex — chromatin and cancer
Roberts, C. W. M., & Orkin, S. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1273 · Cited by 603
Self-citationHighly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
A continuum model for tumour suppression
Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 501
Guan, B., Wang, T.-L., & Shih, I.-M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1562 · Cited by 442
Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma
Li, M., Zhao, H., Zhang, X., Wood, L. D., Anders, R. A., Choti, M. A., Pawlik, T. M., Daniel, H. D., Kannangai, R., Offerhaus, G. J. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.903 · Cited by 427
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
Huang, J., Deng, Q., Wang, Q., Li, K.-Y., Dai, J.-H., Li, N., Zhu, Z.-D., Zhou, B., Liu, X.-Y., Liu, R.-F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2391 · Cited by 385
Recent advances in understanding chromatin remodeling by Swi/Snf complexes
Martens, J. A., & Winston, F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00022-4 · Cited by 353
Gao, X., Tate, P., Hu, P., Tjian, R., Skarnes, W. C., & Wang, Z. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801802105 · Cited by 336
A Specificity and Targeting Subunit of a Human SWI/SNF Family-Related Chromatin-Remodeling Complex
Nie, Z., Xue, Y., Yang, D., Zhou, S., Deroo, B. J., Archer, T. K., & Wang, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8879-8888.2000 · Cited by 300
Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
Guan, B., Mao, T.-L., Panuganti, P. K., Kuhn, E., Kurman, R. J., Maeda, D., Chen, E., Jeng, Y.-M., Wang, T.-L., & Shih, I.-M. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318212782a · Cited by 286
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
Jones, S., Li, M., Parsons, D. W., Zhang, X., Wesseling, J., Kristel, P., Schmidt, M. K., Markowitz, S., Yan, H., Bigner, D., et al. (2012) · Human Mutation · doi:10.1002/humu.21633 · Cited by 285
Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control
Nagl, N. G., Wang, X., Patsialou, A., Van Scoy, M., & Moran, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601541 · Cited by 236
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas
Wiegand, K. C., Lee, A. F., Al‐Agha, O. M., Chow, C., Kalloger, S. E., Scott, D. W., Steidl, C., Wiseman, S. M., Gascoyne, R. D., Gilks, B., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2911 · Cited by 235
Shain, A. H., Giacomini, C. P., Matsukuma, K., Karikari, C. A., Bashyam, M. D., Hidalgo, M., Maitra, A., & Pollack, J. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114817109 · Cited by 221
Betz, B. L., Strobeck, M. W., Reisman, D. N., Knudsen, E. S., & Weissman, B. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205706 · Cited by 212
Katagiri, A., Nakayama, K., Rahman, M. T., Rahman, M., Katagiri, H., Nakayama, N., Ishikawa, M., Ishibashi, T., Iida, K., Kobayashi, H., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.161 · Cited by 212
BRD7 is a candidate tumour suppressor gene required for p53 function
Drost, J., Mantovani, F., Tocco, F., Elkon, R., Comel, A., Holstege, H., Kerkhoven, R., Jonkers, J., Voorhoeve, P. M., Agami, R., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2038 · Cited by 199
Nomenclature of the ARID family of DNA-binding proteins
WILSKER, D., PROBST, L., WAIN, H., MALTAIS, L., TUCKER, P., & MORAN, E. (2005) · Genomics · doi:10.1016/j.ygeno.2005.03.013 · Cited by 160
Nagl, N. G., Patsialou, A., Haines, D. S., Dallas, P. B., Beck, G. R., & Morán, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1225 · Cited by 145
The SWI/SNF Family of ATP-Dependent Chromatin Remodelers: Similar Mechanisms for Diverse Functions
Wang, W. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-55747-7_6 · Cited by 141
Inoue, H., Furukawa, T., Giannakopoulos, S., Zhou, S., King, D., & Tanese, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205961200 · Cited by 141
Mamo, A., Cavallone, L., Tüzmen, Ş., Chabot, C., Ferrario, C., Hassan, S. N., Edgren, H., Kallioniemi, O., Aleynikova, O., Przybytkowski, E., et al. (2011) · Oncogene · doi:10.1038/onc.2011.386 · Cited by 127
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Popovic, R., & Licht, J. D. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0076 · Cited by 126
Mammalian SWI/SNF-A Subunit BAF250/ARID1 Is an E3 Ubiquitin Ligase That Targets Histone H2B
Li, X. S., Trojer, P., Matsumura, T., Treisman, J. E., & Tanese, N. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00540-09 · Cited by 124
Genome profiling of pancreatic adenocarcinoma
Birnbaum, D. J., Adélaïde, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F., Gonçalvès, A., Turrini, O., Delpero, J., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20870 · Cited by 122
Dallas, P. B., Pacchione, S. J., Wilsker, D. F., Bowrin, V., Kobayashi, R., & Morán, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3137-3146.2000 · Cited by 122
Nagl, N. G., Zweitzig, D. R., Thimmapaya, B., Beck, G. R., & Morán, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3427 · Cited by 120
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Maeda, D., Mao, T., Fukayama, M., Nakagawa, S., Yano, T., Taketani, Y., & Shih, I. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11125120 · Cited by 116
Abé, H., Maeda, D., Hino, R., Otake, Y., Isogai, M., Ushiku, A. S., Matsusaka, K., Kunita, A., Ushiku, T., Uozaki, H., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1303-2 · Cited by 113
Reconstitution of Glucocorticoid Receptor-Dependent Transcription In Vivo
Trotter, K. W., & Archer, T. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3347-3358.2004 · Cited by 107
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., & Matsubara, O. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1169-8 · Cited by 98
Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors
Wang, X., Nagl, N. G., Flowers, S. J., Zweitzig, D. R., Dallas, P. B., & Morán, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.20450 · Cited by 95
p300/CREB Binding Protein-Related Protein p270 Is a Component of Mammalian SWI/SNF Complexes
Dallas, P. B., Cheney, I. W., Liao, D.-W., Bowrin, V., Byam, W., Pacchione, S. J., Kobayashi, R., Yaciuk, P., & Morán, E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.6.3596 · Cited by 89
Rodríguez-Nieto, S., Cañada, A., Pros, E., Pinto, A. I., Torres‐Lanzas, J., López‐Ríos, F., Sánchez-Verde, L., Pisano, D. G., & Sánchez‐Céspedes, M. (2010) · Human Mutation · doi:10.1002/humu.21415 · Cited by 88
Flores‐Alcantar, A., Gonzalez‐Sandoval, A., Escalante‐Alcalde, D., & Lomelí, H. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1182-x · Cited by 76
Trotter, K. W., Fan, H.-Y., Ivey, M. L., Kingston, R. E., & Archer, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01301-07 · Cited by 65
Zhang, X., Zhang, Y., Yang, Y., Niu, M., Sun, S., Ji, H., Ma, Y., Yao, G., Jiang, Y., Shan, M., et al. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.07.006 · Cited by 62
Mutations and deletions of ARID1A in breast tumors
Cornen, S., Adélaı̈de, J., Bertucci, F., Finetti, P., Guillé, A., Birnbaum, D. J., Birnbaum, D., & Chaffanet, M. (2012) · Oncogene · doi:10.1038/onc.2011.598 · Cited by 57
Fadare, O., Renshaw, I. L., & Liang, S. X. (2012) · Journal of Cancer · doi:10.7150/jca.4140 · Cited by 50
Target genes of the largest human SWI/SNF complex subunit control cell growth
Inoue, H., Giannakopoulos, S., Parkhurst, C. N., Matsumura, T., Kono, E. A., Furukawa, T., & Tanese, N. (2011) · Biochemical Journal · doi:10.1042/bj20101358 · Cited by 29
Cited by
ROS and the DNA damage response in cancer
Srinivas, U. S., Tan, B. W. Q., Vellayappan, B. A., & Jeyasekharan, A. D. (2019) · Redox Biology · doi:10.1016/j.redox.2018.101084 · Cited by 2,144
Emerging landscape of oncogenic signatures across human cancers
Ciriello, G., Miller, M. L., Aksoy, B. A., Senbabaoglu, Y., Schultz, N., & Sander, C. (2013) · Nature Genetics · doi:10.1038/ng.2762 · Cited by 1,378
Shen, J., Ju, Z., Zhao, W., Wang, L., Peng, Y., Ge, Z., Nagel, Z. D., Zou, J., Wang, C., Kapoor, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0012-z · Cited by 562
From neural development to cognition: unexpected roles for chromatin
Ronan, J. L., Wu, W., & Crabtree, G. R. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3413 · Cited by 544
Helicobacter pylori CagA and Gastric Cancer: A Paradigm for Hit-and-Run Carcinogenesis
Hatakeyama, M. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.008 · Cited by 554
Metadata
- Authors
- Wu, J. N., & Roberts, C. W. M.
- Venue
- Cancer Discovery
- Published
- 2013-01-01
- Volume
- 3
- Issue
- 1
- Pages
- 35-43
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W2124652061
- Cited by
- 456
- References
- 60
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.